跳至主要内容
临床试验/NCT04982263
NCT04982263已完成不适用

Blood Coagulation Abnormalities in COVID-19 Patients and Correlation With Severity

Sohag University1 个研究点 分布在 1 个国家目标入组 125 人开始时间: 2021年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
125
试验地点
1
主要终点
correlation of disease severity with results of laboratory test

研究概览

简要总结

The role of the coagulation parameters in predicting the severity of COVID-19 disease will be assessed

详细描述

In COVID-19 patients the coagulation parameters Prothrombin concentration (PC), Activated Partial Thromboplastin Time (aPTT), D Dimer, Antithrombin III (ATIII) and Fibrinogen are measured and correlation with disease severity is to be investigated

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ● Confirmed cases with COVID 19

排除标准

  • ● Known history of blood coagulopathy disorder

结局指标

主要结局

correlation of disease severity with results of laboratory test

时间窗: Baseline results of coagulation profile and baseline disease severity assessment

The results of blood coagulation profile will be correlated with degree of severity of illness

次要结局

  • Agreement of abnormalities in coagulation profile with measured inflammatory markers(baseline measurement of inflammatory markers)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hend Mohammed Abdelraheem Esmaeel

assistant professor

Sohag University

研究点 (1)

Loading locations...

相似试验